216 related articles for article (PubMed ID: 37047013)
1. Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells.
Rasheed S; Bouley RA; Yoder RJ; Petreaca RC
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047013
[TBL] [Abstract][Full Text] [Related]
2. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.
Burgos ES; Wilczek C; Onikubo T; Bonanno JB; Jansong J; Reimer U; Shechter D
J Biol Chem; 2015 Apr; 290(15):9674-89. PubMed ID: 25713080
[TBL] [Abstract][Full Text] [Related]
3. PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination.
Clarke TL; Sanchez-Bailon MP; Chiang K; Reynolds JJ; Herrero-Ruiz J; Bandeiras TM; Matias PM; Maslen SL; Skehel JM; Stewart GS; Davies CC
Mol Cell; 2017 Mar; 65(5):900-916.e7. PubMed ID: 28238654
[TBL] [Abstract][Full Text] [Related]
4. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Stopa N; Krebs JE; Shechter D
Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
[TBL] [Abstract][Full Text] [Related]
5. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
6. PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes.
Hamard PJ; Santiago GE; Liu F; Karl DL; Martinez C; Man N; Mookhtiar AK; Duffort S; Greenblatt S; Verdun RE; Nimer SD
Cell Rep; 2018 Sep; 24(10):2643-2657. PubMed ID: 30184499
[TBL] [Abstract][Full Text] [Related]
7. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer.
Guo C; Wu L; Zheng X; Zhao L; Hou X; Wang Z; Han C
Curr Top Med Chem; 2023; 23(21):2048-2074. PubMed ID: 37438905
[TBL] [Abstract][Full Text] [Related]
8. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
[TBL] [Abstract][Full Text] [Related]
9. The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions.
Chakrapani B; Khan MIK; Kadumuri RV; Gupta S; Verma M; Awasthi S; Govindaraju G; Mahesh A; Rajavelu A; Chavali S; Dhayalan A
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376131
[TBL] [Abstract][Full Text] [Related]
10. The Structural Effects of Phosphorylation of Protein Arginine Methyltransferase 5 on Its Binding to Histone H4.
Börzsei R; Bayarsaikhan B; Zsidó BZ; Lontay B; Hetényi C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232624
[TBL] [Abstract][Full Text] [Related]
11. PRMT5-mediated homologous recombination repair is essential to maintain genomic integrity of neural progenitor cells.
Wang YJ; Cao JB; Yang J; Liu T; Yu HL; He ZX; Bao SL; He XX; Zhu XJ
Cell Mol Life Sci; 2024 Mar; 81(1):123. PubMed ID: 38459149
[TBL] [Abstract][Full Text] [Related]
12. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
[TBL] [Abstract][Full Text] [Related]
13. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
Liu S; Liu Z; Piao C; Zhang Z; Kong C; Yin L; Liu X
J Exp Clin Cancer Res; 2022 Oct; 41(1):293. PubMed ID: 36199122
[TBL] [Abstract][Full Text] [Related]
14. Role of protein arginine methyltransferase 5 in human cancers.
Xiao W; Chen X; Liu L; Shu Y; Zhang M; Zhong Y
Biomed Pharmacother; 2019 Jun; 114():108790. PubMed ID: 30903920
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Wang M; Fuhrmann J; Thompson PR
Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
[TBL] [Abstract][Full Text] [Related]
16. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
[TBL] [Abstract][Full Text] [Related]
17. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
[TBL] [Abstract][Full Text] [Related]
18. SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.
Jensen-Pergakes K; Tatlock J; Maegley KA; McAlpine IJ; McTigue M; Xie T; Dillon CP; Wang Y; Yamazaki S; Spiegel N; Shi M; Nemeth A; Miller N; Hendrickson E; Lam H; Sherrill J; Chung CY; McMillan EA; Bryant SK; Palde P; Braganza J; Brooun A; Deng YL; Goshtasbi V; Kephart SE; Kumpf RA; Liu W; Patman RL; Rui E; Scales S; Tran-Dube M; Wang F; Wythes M; Paul TA
Mol Cancer Ther; 2022 Jan; 21(1):3-15. PubMed ID: 34737197
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 5: a potential cancer therapeutic target.
Yuan Y; Nie H
Cell Oncol (Dordr); 2021 Feb; 44(1):33-44. PubMed ID: 33469838
[TBL] [Abstract][Full Text] [Related]
20. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms.
Chen Y; Shao X; Zhao X; Ji Y; Liu X; Li P; Zhang M; Wang Q
Biomed Pharmacother; 2021 Dec; 144():112252. PubMed ID: 34619493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
